Human hemoglobin does not contain asymmetric dimethylarginine (ADMA)

Nitric Oxide - Biology and Chemistry

Volumn 27, Issue 1, 2012, Pages 72-74

  Böhmer, Anke ^a   Großkopf, Henning ^a   Jordan, Jens ^a   Tsikas, Dimitrios ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; N(G),N(G) DIMETHYLARGININE; PROTEIN HYDROLYSATE;

CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HEMOLYSATE; HUMAN; HUMAN TISSUE; LETTER; MASS SPECTROMETRY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; ULTRAFILTRATION;

ANIMALS; ARGININE; ERYTHROCYTES; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HEMOGLOBINS; HEMOLYSIS; HUMANS; LINEAR MODELS; MICE;

EID: 84861644821     PISSN: 10898603     EISSN: 10898611     Source Type: Journal    
DOI: 10.1016/j.niox.2012.03.013     Document Type: Letter

References (16)

1. A. Zinellu, S. Sotgia, B. Scanu, L. Deiana, and C. Carru Determination of protein-incorporated methylated arginine reference values in healthy subjects whole blood and evaluation of factors affecting protein methylation Clin. Biochem. 41 2008 1218 1223
2. S.S. Billecke, L.A. Kitzmiller, J.J. Northrup, S.E. Whitesall, M. Kimoto, A.V. Hinz, and L.G. D́Alecy Contribution of whole blood to the control of plasma asymmetrical dimethylarginine Am. J. Physiol. Heart Circ. Physiol. 291 2006 H1788 H1796
3. S.S. Billecke, L.G. D'Alecy, R. Platel, S.E. Whitesall, K.A. Jamerson, R.L. Perlman, and C.A. Gadegbeku Blood content of asymmetric dimethylarginine: new insights into its dysregulation in renal disease Nephrol. Dial. Transplant. 24 2009 489 496
4. L.G. D'Alecy, and S.S. Billecke Massive quantities of asymmetric dimethylarginine (ADMA) are incorporated in red blood cell proteins and may be released by proteolysis following hemolytic stress Blood Cells Mol. Dis. 45 2010 40
5. J.M. Leiper, and P. Vallance The synthesis and metabolism of asymmetric dimethylarginine (ADMA) Eur. J. Clin. Pharmacol. 26 2006 33 38
6. H. Lenzen, D. Tsikas, and R.H. Böger Asymmetric dimethylarginine (ADMA) and the risk for coronary heart disease. The multicenter CARDIAC study Eur. J. Clin. Pharmacol. 62 2006 45 49
7. D. Tsikas, R.H. Böger, J. Sandmann, S.M. Bode-Böger, and J.C. Frölich Endogenous nitric oxide synthase inhibitors are responsible for the L-arginine paradox FEBS Lett. 478 2000 1 3
8. R. Maas, J. Tan-Andreesen, E. Schwedhelm, F. Schulze, and R.H. Böger A stable-isotope based technique for the determination of dimethylarginine dimethylaminohydrolase (DDAH) activity in mouse tissue J. Chromatogr. B 851 2007 220 228
9. D. Tsikas, and B. Beckmann Albumin from human serum does not contain asymmetric dimethylarginine (ADMA) Clin. Biochem. 42 2009 1739 1740
10. D. Tsikas, S. Engeli, B. Beckmann, and J. Jordan Asymmetric dimethylarginine (ADMA) is present in plasma proteins of healthy subjects at the low nmol-per-g-level Nitric Oxide 22 2010 316 317
11. A. Zinellu, S. Sotgia, B. Scanu, M. Formato, L. Deiana, and C. Carru Assessment of protein-incorporated arginine methylation in biological specimens by CZE UV-detection Electrophoresis 28 2007 4452 4458
12. D. Tsikas, B. Schubert, F.M. Gutzki, J. Sandmann, and E. Schwedhelm Quantitative determination of circulating and urinary asymmetric dimethylarginine (ADMA) in humans by gas chromatography-tandem mass spectrometry as methyl ester tri(N-pentafluoropropionyl) derivative J. Chromatogr. B 798 2003 87 99
13. B. Beckmann, F.M. Gutzki, and D. Tsikas Sensitivity enhancement of a GC-MS/MS method for asymmetric dimethylarginine (ADMA) by plasma ultrafiltrate reduction Anal. Biochem. 372 2 2008 264 266
14. N. Bader, and T. Grune Protein oxidation and proteolysis Biol. Chem. 387 2006 1351 1355
15. A. Böhmer, J. Jordan, and D. Tsikas High-performance liquid chromatography ultraviolet assay for human erythrocytic catalase activity by measuring glutathione as o-phthalaldehyde derivative Anal. Biochem. 410 2011 296 303
16. J. Axelrod, and C.K. Cohn Methyltransferase enzyme in red blood cells J. Pharmacol. Exp. Ther. 176 1971 650 654